Evoke Pharma Income Statement (2020-2025) | EVOK

1Y3Y5Y7Y10YAll
Download Data
Income Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue -0.00M-0.05M-0.06M0.09M0.24M0.93M0.36M0.42M0.46M0.83M0.80M0.81M1.13M1.56M1.68M1.74M2.55M2.65M3.31M3.08M3.75M4.28M
Cost of Revenue 0.06M0.07M0.06M0.14M0.02M0.07M0.09M0.19M0.05M0.06M0.03M0.06M0.09M0.04M0.10M0.12M0.04M0.17M0.10M
Gross Profit 0.03M0.17M0.87M0.22M0.40M0.39M0.74M0.61M0.76M1.07M1.53M1.62M1.64M2.51M2.55M3.19M3.04M3.58M4.18M
Operating items
Research & Development 5.78M0.21M0.10M0.28M0.20M0.08M0.04M0.04M0.19M0.04M0.03M0.07M0.09M0.02M0.00M0.01M0.04M0.01M0.01M
Selling, General & Administrative 1.18M1.87M2.04M2.34M2.14M2.64M1.74M2.41M2.32M2.61M2.29M2.85M2.77M3.13M3.48M3.14M3.73M3.82M4.38M4.30M5.13M5.31M
Other Operating Expenses 0.09M0.06M0.07M0.06M0.14M0.02M0.07M0.09M0.19M0.05M0.06M0.03M0.06M0.09M0.04M0.10M0.12M0.04M0.17M0.10M
Operating Expenses 6.96M2.08M2.23M2.68M2.41M2.78M1.91M2.47M2.57M2.74M2.51M2.97M2.92M3.17M3.56M3.24M3.77M3.94M4.50M4.38M5.31M5.42M
Operating Income -6.96M-2.08M-2.21M-2.59M-2.17M-1.84M-1.55M-2.05M-2.11M-1.91M-1.71M-2.16M-1.78M-1.60M-1.89M-1.50M-1.22M-1.29M-1.19M-1.30M-1.56M-1.14M
EBIT -6.96M-2.08M-2.21M-2.59M-2.17M-1.84M-1.55M-2.05M-2.11M-1.91M-1.71M-2.16M-1.78M-1.60M-1.89M-1.50M-1.22M-1.29M-1.19M-1.30M-1.56M-1.14M
Non-operating items
Interest & Investment Income 485.000.00M776.000.00M0.00M0.00M0.00M795.000.00M0.02M0.03M0.04M0.04M0.04M0.03M0.05M0.08M0.10M0.13M0.12M0.11M0.11M
Other Non Operating Income -0.09M-0.10M-0.08M-0.04M-0.03M932.00-0.00M-0.01M-0.02M
Non Operating Income -0.00M-0.05M-0.06M-0.02M-0.12M-0.12M-0.13M-0.12M-0.12M-0.10M-0.09M-0.09M-0.08M-0.09M-0.10M-0.08M-0.04M-0.03M932.00-0.00M-0.01M-0.02M
Net income details
EBT -6.97M-2.13M-2.27M-2.71M-2.29M-1.97M-1.67M-2.17M-2.23M-2.01M-1.80M-2.24M-1.87M-1.69M-1.99M-1.58M-1.27M-1.31M-1.19M-1.31M-1.57M-1.16M
Profit After Tax -6.97M-2.13M-2.27M-2.61M-2.29M-1.97M-1.67M-2.17M-2.23M-2.01M-1.80M-2.24M-1.87M-1.69M-1.99M-1.58M-1.27M-1.31M-1.19M-1.31M-1.57M-1.16M
Income from Continuing Operations -6.97M-2.13M-2.27M-2.71M-2.29M-1.97M-1.67M-2.17M-2.23M-2.01M-1.80M-2.24M-1.87M-1.69M-1.99M-1.58M-1.27M-1.31M-1.19M-1.31M-1.57M-1.16M
Consolidated Net Income -6.97M-2.13M-2.27M-2.71M-2.29M-1.97M-1.67M-2.17M-2.23M-2.01M-1.80M-2.24M-1.87M-1.69M-1.99M-1.58M-1.27M-1.31M-1.19M-1.31M-1.57M-1.16M
Income towards Parent Company -6.97M-2.13M-2.27M-2.71M-2.29M-1.97M-1.67M-2.17M-2.23M-2.01M-1.80M-2.24M-1.87M-1.69M-1.99M-1.58M-1.27M-1.31M-1.19M-1.31M-1.57M-1.16M
Net Income towards Common Stockholders -6.97M-2.13M-2.27M-2.71M-2.29M-1.97M-1.67M-2.17M-2.23M-2.01M-1.80M-2.24M-1.87M-1.69M-1.99M-1.58M-1.27M-1.31M-1.19M-1.31M-1.57M-1.16M
Additional items
EPS (Basic) -0.28-0.08-0.09-0.08-0.85-0.73-0.61-0.80-0.71-0.60-0.53-0.67-6.71-6.08-7.13-2.09-0.93-0.94-0.63-0.51-0.62-0.45
EPS (Weighted Average and Diluted) -0.85-0.73-0.61-0.80-0.71-0.60-0.53-0.67-6.71-6.08-7.13-2.09-0.93-0.94-0.63-0.51-0.62-0.45
Shares Outstanding (Weighted Average) 24.44M24.99M26.15M25.49M31.16M2.70M2.71M2.68M2.73M3.16M3.34M3.14M3.34M0.28M0.28M0.28M0.76M1.36M1.40M1.91M2.55M2.55M2.56M
Shares Outstanding (Diluted Average) 2.70M2.71M2.68M2.73M3.16M3.34M3.14M3.34M0.28M0.28M0.28M0.76M1.36M1.40M1.91M2.55M2.55M2.56M
EBITDA -6.96M-2.08M-2.21M-2.59M-2.17M-1.84M-1.55M-2.05M-2.11M-1.91M-1.71M-2.16M-1.78M-1.60M-1.89M-1.50M-1.22M-1.29M-1.19M-1.30M-1.56M-1.14M
Interest Expenses 0.00M0.05M0.06M0.12M0.12M0.13M0.13M0.12M0.12M0.13M0.13M0.12M0.12M0.13M0.13M0.12M0.12M0.13M0.13M0.12M0.12M0.13M